📰 Significant Decrease News
Significant Decrease News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Significant Decrease. Real-time updates on events, politics, business and more.
April 1, 2024
February 2024 Statistics Show a Significant Decrease in Unemployment for Many Counties Nashville, TN - More Tennesseans started the second month of 2024
February 1, 2024
Explore the reasons behind Shell's considerable decrease in profit in 2023, from market volatility to an increase in LNG profits. Understand Shell's financial landscape in this detailed review.
November 6, 2023
Afghanistan Latest News: In a significant development, opium poppy cultivation in Afghanistan has witnessed a staggering decline of 95 percent after the countrys acting government implemented a ban on the drug in April 2022, according to the United Nations Office on Drugs and Crime (UNODC).
August 2, 2023
Eurozone Unemployment Rate Reaches 6.4% in June 2023 Eurostat, the European statistical office, announced that the eurozone unemployment rate reached 6.4%
July 31, 2023
Alcohol is linked to weight gain but does alcohol stop fat burning? Find out the real science behind alcohol, fat burning & weight gain 2023.
April 23, 2021
Sanofi: New Dupixent (dupilumab) analyses reinforce long-term safety and efficacy profile in patients with atopic dermatitis as young as 6 years as young as 6 years Nearly 30 data presentations at AAD and ESPD across clinical and real-world settings, including the impact of Dupixent on disease measures in uncontrolled moderate-to-severe atopic dermatitis Late-breaking Phase 2 data for rilzabrutinib, an investigational therapy for pemphigus vulgaris, a rare, debilitating autoimmune disease, to...
February 18, 2021
Investegate announcements from Immunic, Inc., Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis
February 18, 2021
DGAP-News: Immun ... DGAP-News: Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis vom 18.02.2021, 12:30 Uhr Bild: pixabay.com DGAP-News: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis 18.02.2021 / 12:30 The issuer is solel...